Cemiplimab for Orbital Squamous Cell Carcinoma in 11 Cases

Steren, B; Burtness, B; Bhatia, A; Demirci, H; Shinder, R; Yoo, D; Tse, B; Pointdujour-Lim, R

Pointdujour-Lim, R (通讯作者),Yale Sch Med, Dept Ophthalmol & Visual Sci, 35 Pk St, New Haven, CT 06510 USA.

OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022; 38 (5): 496

Abstract

Purpose: To review the demographics, clinical features, and response of orbital squamous cell carcinoma treated with cemiplimab. Methods: This is a re......

Full Text Link